Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Tipo de estudo
Intervalo de ano
1.
Medical Principles and Practice. 2007; 16 (2): 158-160
em Inglês | IMEMR | ID: emr-84466

RESUMO

To describe two cases of primary omental torsion as an uncommon cause of abdominal pain. Two female patients presented to our surgical service with right-sided abdominal pain. In view of their clinical presentation and workup, both patients required operative intervention. At laparotomy, the cause of the pain was recognized to be due to infarcted omentum secondary to torsion. Both patients underwent omentectomy and appendectomy and had an uneventful recovery. Primary torsion of the omentum is difficult to diagnose preoperatively; this condition is usually detected during surgical exploration for acute abdominal pain


Assuntos
Humanos , Feminino , Anormalidade Torcional , Doenças Peritoneais/diagnóstico , Dor Abdominal , Infarto , Abdome Agudo
2.
Medical Principles and Practice. 2007; 16 (2): 161-163
em Inglês | IMEMR | ID: emr-84467

RESUMO

To report a case of right posterior subcapsular cataract induced by 3-monthly depot luteinizing hormone-releasing hormone [LHRH] analogue therapy in a patient with early prostate cancer. A 52-year-old male with static myopia of several years' duration was given a 3-month depot LHRH analogue [goserelin 10.8 mg] as part of neoadjuvant treatment for early prostate cancer. Four weeks after the treatment, the patient developed right posterior subcapsular cataract commonly associated with steroid treatment. The patient had right eye cataract extraction followed by insertion of a new lens. This report shows a case of a posterior subcapsular cataract as an adverse reaction to depot goserelin acetate. This is a feature commonly seen in steroid-induced cataract. Patients with prostate cancer and poor vision if due to cataract may not be ideal patients for depot preparations of LHRH analogues


Assuntos
Humanos , Masculino , Hormônio Liberador da Corticotropina/análogos & derivados , Hormônio Liberador da Corticotropina , Catarata/induzido quimicamente , Neoplasias da Próstata/complicações , Terapia Neoadjuvante , Metástase Neoplásica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA